Advertisement
Images in Neuroscience: Answer| Volume 24, P170, February 2016

Download started.

Ok

Recurrent episodes of stroke in a young adult: answer

Published:September 22, 2015DOI:https://doi.org/10.1016/j.jocn.2015.08.001

      1. Answer

      C. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

      2. Discussion

      The fluid attenuated inversion recovery MRI (Fig. 1A of the Images in Neuroscience: Question) shows areas of abnormal, asymmetrical high signal changes in the bilateral parieto-occipital regions. The corresponding diffusion-weighted image (Fig. 1B of Images in Neuroscience: Question) reveals restricted diffusion, and there was corresponding low signal in the same region on the apparent diffusion coefficient map (not shown), suggestive of an acute infarction in the right parieto-occipital region, indicating the different time frames (acute right sided and prior left sided infarcts) of the bilateral parieto-occipital lesions. The corresponding technetium-99m Neurolite single photon emission computed tomographic scan (Supp. Fig. 1) shows a perfusion defect in the left parieto-occipital region.
      In this young man, the sequentially occurring multi-focal lesions in different vascular distributions may indicate an embolic source [
      • Rovira A.
      • Grivé E.
      • Rovira A.
      • et al.
      Distribution territories and causative mechanisms of ischemic stroke.
      ]. However, his cardiac work up, thrombophilia screen and vascular imaging were unrevealing. In this otherwise cryptogenic stroke syndrome, the key neuroimaging features are the non-conformity of the left parieto-occipital lesion to a distinct vascular distribution. While the parietal lobe (and the contiguous Wernicke’ area) lies in the anterior circulation (posterior division of the middle cerebral artery territory), the occipital cortex (with the exception of the occipital pole) is supplied from the posterior circulation (supplied by the posterior cerebral artery). Additionally, the brain lesions are confined mostly to the gray matter. In the absence of atherosclerotic risk factors, these features, apart from the elevated lactate on cerebral MRI spectroscopy (Supp. Fig. 2) and in the plasma, prompted the consideration of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) [
      • Hirano M.
      • Ricci E.
      • Koenigsberger M.R.
      • et al.
      MELAS: an original case and clinical criteria for diagnosis.
      ]. The diagnosis was ultimately confirmed by molecular genetic testing which revealed a 3243A > G mutation in the mitochondrially encoded tRNA leucine 1 gene in the peripheral lymphocytes (Supp. Fig. 3). The other competing diagnoses were ruled out in the absence of the typical clinical and radiological features. For instance, MRI lesions in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) involve characteristic locations, namely the bilateral anterior temporal white matter and external capsules [
      • Ballabio E.
      • Bersano A.
      • Bresolin N.
      • et al.
      Monogenic vessel diseases related to ischemic stroke: a clinical approach.
      ]. Other conditions such as hereditary endotheliopathy with retinopathy, nephropathy and stroke (HERNS - now named retinal vasculopathy with cerebral leukodystrophy) and Fabry disease are multi-systemic conditions with renal, ocular and cutaneous features [
      • Ballabio E.
      • Bersano A.
      • Bresolin N.
      • et al.
      Monogenic vessel diseases related to ischemic stroke: a clinical approach.
      ]. Fabry disease has the characteristic imaging finding of pulvinar hyperintensity on T1-weighted MRI. Our patient received levetiracetam for seizure prophylaxis and L-arginine, with no more stroke-like episodes recorded at subsequent follow-up.
      The neuroimaging findings in Figure 1A, B and Supplementary Figure 1 in Images in Neuroscience: Question, may aid neurologists in the diagnosis of MELAS. The protean clinical features of MELAS span different specialties and may pose considerable diagnostic challenges for clinicians. However, full closure of the diagnosis is important to avoid expensive and invasive tests (such as conventional angiography) and to mitigate the anxiety of the patients and clinicians in the setting of recurrent stroke-like episodes. From a pharmacological view point, valproic acid and propofol are usually contraindicated for seizure management in this setting [
      • Neustadt J.
      • Pieczenik S.R.
      Medication-induced mitochondrial damage and disease.
      ]. Apart from Class IV evidence that favors L-arginine [a nitric oxide (endogenous vasodilator agent) donor] for the stroke-like episodes, there are no other specific treatment options [
      • Koga Y.
      • Akita Y.
      • Nishioka J.
      • et al.
      L-arginine improves the symptoms of stroke like episodes in MELAS.
      ]. The putative stroke mechanisms in this maternally inherited disorder include mitochondrial angiopathy and energy failure, vascular dysfunction, and altered neuronal excitability [
      • Minobe S.
      • Matsuda A.
      • Mitsuhashi T.
      • et al.
      Vasodilatation of multiple cerebral arteries in early stage of stroke-like episode with MELAS.
      ].

      Appendix A. Supplementary material

      Figure thumbnail fx1
      Supplementary Fig. 1Axial cerebral Technetium-99m Neurolite single photon emission computed tomographic perfusion scan (Lantheus Medical Imaging, Billerica, MA, USA; corresponds to the neuroimaging in Figure 1).
      Figure thumbnail fx2
      Supplementary Fig. 2Multi-voxel cerebral MRI spectroscopy (with an echo time of 135 ms) adjacent to the left parieto-occipital lesion, showing an elevated lipid and lactate peak at 1.3 parts per million. Inset images: Axial (top), coronal (middle), sagittal (bottom) brain MRI.
      • Supplementary Fig. 3

        DNA sequence chromatogram of the patient (A) showing a heteroplasmic mutation m.3243A > G at position 14 (base marked R) in comparison with the wild type allele of mitochondrial DNA (B).

      References

        • Rovira A.
        • Grivé E.
        • Rovira A.
        • et al.
        Distribution territories and causative mechanisms of ischemic stroke.
        Eur Radiol. 2005; 15: 416-426
        • Hirano M.
        • Ricci E.
        • Koenigsberger M.R.
        • et al.
        MELAS: an original case and clinical criteria for diagnosis.
        Neuromuscul Disord. 1992; 2: 125-135
        • Ballabio E.
        • Bersano A.
        • Bresolin N.
        • et al.
        Monogenic vessel diseases related to ischemic stroke: a clinical approach.
        J Cereb Blood Flow Metab. 2007; 27: 1649-1662
        • Neustadt J.
        • Pieczenik S.R.
        Medication-induced mitochondrial damage and disease.
        Mol Nutr Food Res. 2008; 52: 780-788
        • Koga Y.
        • Akita Y.
        • Nishioka J.
        • et al.
        L-arginine improves the symptoms of stroke like episodes in MELAS.
        Neurology. 2005; 64: 710-712
        • Minobe S.
        • Matsuda A.
        • Mitsuhashi T.
        • et al.
        Vasodilatation of multiple cerebral arteries in early stage of stroke-like episode with MELAS.
        J Clin Neurosci. 2015; 22: 407-408

      Linked Article

      • Recurrent episodes of stroke in a young adult: question
        Journal of Clinical NeuroscienceVol. 24
        • Preview
          A 30-year-old short statured man, without vascular risk factors including hypertension, diabetes mellitus, smoking, hyperlipidemia, sickle cell disease, and cardiomyopathy, was evaluated for two stroke-like episodes. In the first episode (at 28 years of age), he developed a sudden onset of receptive aphasia with right hemianopsia, and made a remarkable recovery. His fundi and retina were normal. Two years later, he presented with a second episode, characterized by an attack of generalized tonic-clonic seizure with prolonged postictal inattention and confusion.   
        • Full-Text
        • PDF